1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1038/ki.2011.500
DC FieldValue
dc.titleAntibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: New insights
dc.contributor.authorMacDougall, I.C.
dc.contributor.authorRoger, S.D.
dc.contributor.authorDe Francisco, A.
dc.contributor.authorGoldsmith, D.J.A.
dc.contributor.authorSchellekens, H.
dc.contributor.authorEbbers, H.
dc.contributor.authorJelkmann, W.
dc.contributor.authorLondon, G.
dc.contributor.authorCasadevall, N.
dc.contributor.authorHörl, W.H.
dc.contributor.authorKemeny, D.M.
dc.contributor.authorPollock, C.
dc.date.accessioned2016-07-10T02:35:39Z
dc.date.available2016-07-10T02:35:39Z
dc.date.issued2012-04-02
dc.identifier.citationMacDougall, I.C., Roger, S.D., De Francisco, A., Goldsmith, D.J.A., Schellekens, H., Ebbers, H., Jelkmann, W., London, G., Casadevall, N., Hörl, W.H., Kemeny, D.M., Pollock, C. (2012-04-02). Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: New insights. Kidney International 81 (8) : 727-732. ScholarBank@NUS Repository. https://doi.org/10.1038/ki.2011.500
dc.identifier.issn00852538
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125799
dc.description.abstractAntibody-mediated pure red cell aplasia is a very rare but devastating condition affecting patients receiving treatment with erythropoiesis-stimulating agents. New cases continue to emerge, generally in clusters, consistent with an 'environmental' trigger to its pathogenesis. Defining the causes of antibody-mediated pure red cell aplasia is clearly of importance for patients with chronic kidney disease, but any developments in this area may also have relevance to other disease areas as therapeutic delivery of endogenous proteins rapidly increases. This review focuses on the current knowledge regarding the etiology of antibody-mediated pure red cell aplasia and the current approach to therapy. © 2012 International Society of Nephrology.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/ki.2011.500
dc.sourceScopus
dc.subjectanemia
dc.subjectchronic kidney disease
dc.subjectclinical nephrology
dc.subjectpure red cell aplasia
dc.typeOthers
dc.contributor.departmentMICROBIOLOGY
dc.description.doi10.1038/ki.2011.500
dc.description.sourcetitleKidney International
dc.description.volume81
dc.description.issue8
dc.description.page727-732
dc.description.codenKDYIA
dc.identifier.isiut000302269300004
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.